Navigation Links
Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007
Date:11/20/2007

______ ______ ______ ______

Total 15,000 15,749 5,469 5,320

--------- --------- --------- ---------

Gross profit

Refining 943 817 235 133

Polymers 139 54 51 (12)

Aromatics 166 86 52 12

______ ______ ______ ______

Total 1,248 957 338 133

--------- --------- --------- ---------

Sales, general and

administrative expenses

Refining 192 149 55 46

Polymers 39 26 14 7

Aromatics 80 62 31 23

______ ______ ______ ______

Total 311 237 100 76

--------- --------- --------- ---------

Operating income

Refining 751 668 180 87

Polymers 100 28 37 (19)

Aromatics 86 24 21 (11)

______ ______ ______ ______

Total 937 720 238 57

--------- --------- --------- ---------

______ ______ ______ ______

Financing (expenses) income, net (80) (92) 3 (24)

______ ______ ______ ______

Privatization grant
'/>"/>

SOURCE Oil Refineries Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov.25/PRNewswire/--BiotechfirmReplikinsLtd.,which...emicthroughtheprediction,outbreak,andprogressofthe...lanalysisofthevirus.Thenewdatashowsthatthelethalit...3.7(s.d.4.5)duringthevirus,scurrentoutbreakinthesp...(s.d.0.1).TheH1N1virus,infectivitycount,however,re...
(Date:11/25/2009)...,Nov.25/PRNewswire/--Reportlinker.comannouncesthat... ,, BrazilBioethanolMarketAnalysisandForecasts...3/Brazil-Bioethanol-Market-Analysis-and-Forecasts-...andForecaststo2013 ,, Summary ,, Thereport...ethanolmarketandtheBrazilbioethanolmarketinparticu...
(Date:11/24/2009)... The New York investment bank KTA Capita...s agreed an AU$6.7 mil convertible note private pl...ivate placement was arranged by KTA Capital as Neu... New York (PRWEB) November 23... KTA Capital, LLC ("KTA Capital") has an...
(Date:11/24/2009)... Health care employment grew by 29,000...ne to show consistent growth during the U.S. reces...ain in trouble, and health systems are coming clos...stead of just administrators. , ...ployment continued growing in October despite the ...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... Feb. 24 /PRNewswire-FirstCall/ - Angiotech Pharma...bal specialty pharmaceutical and medical device co... quarter and year end conference call. The call wi...day, March 5, 2009. , , , Dial information for...d, and is as follows:, North America (toll-f...
...s Effect on Reduction of Exacerbations is the Attr... Decisions, According to a New Report from Decisio... Resources, one of the world,s leading research an... issues, finds that Novartis/Schering-Plough,s ind...bicort as Decision Resources, proprietary clinical...
... Highlighted by Cinryze(TM) [C1 Inhibitor (human)]...roPharma Incorporated (Nasdaq: VPHM ) reported t...and year ended December 31, 2008. , , Key events ...: , , , Closed on acquisition of Lev Pha...Initiated commercial launch of Cinryze for routine...
Other Biology Technology:Novartis/Schering-Plough's Drug Will Replace AstraZeneca's Symbicort as Decision Resources' Clinical Gold Standard by 2012 for the Treatment of Asthma 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 4ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 5ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 6ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 7ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 8ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 9ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 10ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 11ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 12
(Date:11/23/2009)...ommunity-associated strain of the deadly superbug ...t common antibioticsposes a far greater health thr...to hospitals, according to a study in the December... new threat is easily picked up in fitness centers...ed the overall burden of MRSA within hospitals, th...
(Date:11/23/2009)...ldlife Conservation Society says that western lowl...ic of Congopart of the "mother lode" of more than ...increasingly threatened by growing humans activity...n of the swamp forests adjacent to the southwest b...veys confirmed that high densities of the great ap...
(Date:11/23/2009)...w study provides "incontrovertible evidence" that ...of Sumatra about 73,000 years ago deforested much ...ter, researchers report. , The volcano ejected a...tmosphere, leaving a crater (now the world,s large...35 kilometers wide. Ash from the event has been fo...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Free LASIK Surgery Webinar 62029 1Free LASIK Surgery Webinar 62029 2Free LASIK Surgery Webinar 62029 3Free LASIK Surgery Webinar 62029 4TeamStaff Announces Transfer to Nasdaq Capital Market 62025 1TeamStaff Announces Transfer to Nasdaq Capital Market 62025 2TeamStaff Announces Transfer to Nasdaq Capital Market 62025 3Lives Compromised and Patient Access Limited with New Cuts to Medicare 62021 1Lives Compromised and Patient Access Limited with New Cuts to Medicare 62021 2
...erimental procedure that dramatically strengthens ...ould offer new hope to sufferers of muscle-wasting... according to researchers from the University of N...e has been successfully used to regrow muscles in ...ue-based illnesses in humans such as in the liver,...
... professionals send genes and healthy cells on the...or example, repair tissue damage to arteries. But ...tities? Scientists of the PTB have developed a hig...ciency of this therapy can be investigated: Small ...ed gene or on the planted cell can with the aid of...
...g to shed new light on HIV,s ability to survive in...e of Allergy and Infectious Diseases at the NIH ha...DS research team at the New York University Colleg... of HIV replication that involves cooperation betw..., an Assistant Professor of Basic Science and Cran...
Other Biology News:Stem cell breakthrough gives new hope to sufferers of muscle-wasting diseases 2NYU College of Dentistry awarded $1.9 million NIH grant for HIV research 2
...ustom peptide synthesis with a wide variety of pur...our research needs. Purity: IG(>50%), >70%, >80... to 120 residues Modifications: Biotin, Fluores... D-amino acids, MAPs, KLH/BSA conjugation, and muc...
...o 10 represents a major advance in liquid dispensi...large robotic liquid handlers into the realm of th...lumes ranging from 10mL to 2mL per well, the micro...enchtop dispensers. ,Features: , Never nee...
Human CALCA EIA (Enzyme immunoassay) Kit, Host: Rabbit ; Extraction-free from BACHEM
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, CD from PerkinElmer
Biology Products: